A Phase I Study of PLX8394 Plus Ritonavir in Children with Recurrent or Progressive BRAF Activated Gliomas
A Phase I Study of PLX8394 Plus Ritonavir in Children with Recurrent or Progressive BRAF Activated Gliomas
Principal Institutions: Children’s Hospital of Los Angeles in partnership with the Pediatric Brain […]